I agree that this site is using cookies. You can find further informations here.
X
Roeters-van Lennep, J.
191  results:
Search for persons X
?
1

A Distinct Ldl Profile To Predict The Risk Of Cardiovascula..:

Hoogendoorn, A. ; den Hoedt, S. ; van der Zee-van Vark, L....
Atherosclerosis.  287 (2019)  - p. e220 , 2019
Link: https://doi.org/10.1016/..
 
?
2

Persistent monocyte activation in patients with elevated LD..:

Bekkering, S. ; Bernelot-Moens, S.J. ; Verweij, S.L....
Atherosclerosis.  275 (2018)  - p. e2-e3 , 2018
Link: https://doi.org/10.1016/..
 
?
3

SESSION 60: PCOS AND AMH:

Louwers, Y. V. ; Roest-Schalken, M. ; Roeters-van Lennep, J....
Human Reproduction.  27 (2012)  suppl 2 - p. ii87-ii90 , 2012
Link: https://doi.org/10.1093/..
 
?
4

Sex difference in the incidence of microvascular complicati..:

Singh, Sunny S. ; Roeters-van Lennep, Jeanine E. ; Lemmers, Roosmarijn F. H....
Acta Diabetologica.  57 (2020)  6 - p. 725-732 , 2020
Link: https://doi.org/10.1007/..
 
?
5

O121. Maternal metabolic outcomes in women with a history o..:

Benschop, Laura ; Roeters-van Lennep, Jeanine E. ; Schalekamp-Timmermans, Sarah...
Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health.  5 (2015)  3 - p. 236 , 2015
Link: https://doi.org/10.1016/..
 
?
6

Worldwide experience of homozygous familial hypercholestero..:

Tromp T. R ; Hartgers M. L ; Hovingh G. K...
info:eu-repo/semantics/altIdentifier/pmid/35101175.  , 2022
Link: http://hdl.handle.net/24..
 
?
7

Worldwide experience of homozygous familial hypercholestero..:

Tromp, Tycho R ; Hartgers, Merel L ; Hovingh, G Kees...
info:eu-repo/semantics/altIdentifier/pmid/35101175.  , 2022
Link: http://hdl.handle.net/11..
 
?
8

Predicting non-adherence in patients with familial hypercho..:

Galema-Boers, J. M. H. ; Lenzen, M. J. ; van Domburg, R. T....
European Journal of Clinical Pharmacology.  70 (2014)  4 - p. 391-397 , 2014
Link: https://doi.org/10.1007/..
 
?
9

The Cycle study: a prospective study on cholesterol levels ..:

Mulder, J ; Balsrud, P ; Schreuder, M...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
10

Effect of evolocumab versus placebo added to standard lipid..:

Heidemann, B E ; Koopal, C ; Roeters Van Lennep, J E...
European Heart Journal.  43 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
11

The challenge of choosing in cardiovascular risk management:

Hoogeveen, R. M. ; Hanssen, N. M. J. ; Brouwer, J. R....
Netherlands Heart Journal.  30 (2021)  1 - p. 47-57 , 2021
Link: https://doi.org/10.1007/..
 
?
12

Lomitapide in the long-term real-world management of HoFH –..:

Cegla, J. ; d'Erasmo, L. ; Steward, K....
Atherosclerosis Plus.  49 (2022)  - p. S2-S3 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Cardiac medication use in patients with suspected ischaemia..:

Mommersteeg, P. M. C. ; Roeters van Lennep, J. ; Widdershoven, J.
Netherlands Heart Journal.  29 (2021)  10 - p. 506-517 , 2021
Link: https://doi.org/10.1007/..
 
?
14

Sex steroids and markers of micro- and macrovascular damage..:

Aribas, E ; Ahmadizar, F ; Mutlu, U...
European Journal of Preventive Cardiology.  29 (2021)  9 - p. 1322-1330 , 2021
Link: https://doi.org/10.1093/..
 
?
15

Impact of preventive screening and lifestyle interventions ..:

Lagerweij, GR ; Brouwers, L ; De Wit, GA...
European Journal of Preventive Cardiology.  27 (2020)  13 - p. 1389-1399 , 2020
Link: https://doi.org/10.1177/..
 
1-15